Open AccessHospitalized Older Patients with Clostridioides difficile Infection Refractory to Conventional Antibiotic Therapy Benefit from Fecal Microbiota Transplant
Author(s) -
Jae Hyun Shin,
Rachel Hays,
Cirle A. Warren
Publication year - 2021
Publication title -
advances in geriatric medicine and research
Language(s) - English
Resource type - Journals
ISSN - 2632-9921
DOI - 10.20900/agmr20210012
Subject(s) - medicine , refractory (planetary science) , clostridioides , pseudomembranous colitis , clostridium difficile , fecal bacteriotherapy , population , surgery , antibiotics , gastroenterology , physics , environmental health , astrobiology , microbiology and biotechnology , biology
Options for Clostridioides difficile infection (CDI) refractory to conventional therapy are limited. Fecal microbiota transplant (FMT) is considered safe and effective treatment for recurrent CDI and could be a treatment option for refractory CDI. We investigated the efficacy and safety of FMT in hospitalized patients who were not responding to standard treatments for CDI.